• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 7, Issue 5
  3. Authors

Online ISSN: 2515-8260

Volume7, Issue5

DNA based CGB methylation in breast cancer a case control study

    Dr. Anjana Vasudevan Dr. Vasugi. G. A. Dr. R. Ponniah Iyyappan Dr. Harpreet Kaur Dr. Balaji Singh Dr. Guru Prasad Dr. C. S. Subramanium Dr. C. Kaliyappa

European Journal of Molecular & Clinical Medicine, 2020, Volume 7, Issue 5, Pages 55-61

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Breast carcinoma is the most commonly diagnosed cancer and the leading cause of cancer death. Breast cancer also produces and is influenced by ectopic hormones. Beta Human Chorionic Gonadotropin (hCG) is one such hormone and is encoded by chorionic gonadotropin beta (CGB) genes. The aim of this study was to determine the CGB gene methylation in breast cancer tissues and compare them with normal tissues.
Materials and methods: After approval from Institutional Ethical Committee (IEC), consent from patients were obtained. Normal and tumour tissues from breast cancer patients were taken. DNA was isolated from normal and tumour tissues. Post bisulfate conversion samples were processed for qPCR using methylation specific primers for the set of selected CGB genes and SYBR green.
Results: 1-2M was found to be significantly higher among the normal tissues (50.22). 3-9M was found to be 65.93 in tumour tissues and 5.05 in normal tissues and this was significant.
Conclusion: 3-9 M is significantly higher in tumour tissues compared to normal tissues and 1-2 M is significantly higher in normal tissues. This suggests that there are 2 different types of beta hCG secreted by two different types of genes and this can be used for further analysis as a part of future projects. This may help in formulating a new treatment process and may also be used as a tumour marker in high risk patients
Keywords:
    breast cancer genetics cgb genes methylation specific PCR bisulfite conversion
  • PDF (396 K)
  • XML
(2020). DNA based CGB methylation in breast cancer a case control study. European Journal of Molecular & Clinical Medicine, 7(5), 55-61.
Dr. Anjana Vasudevan; Dr. Vasugi. G. A.; Dr. R. Ponniah Iyyappan; Dr. Harpreet Kaur; Dr. Balaji Singh; Dr. Guru Prasad; Dr. C. S. Subramanium; Dr. C. Kaliyappa. "DNA based CGB methylation in breast cancer a case control study". European Journal of Molecular & Clinical Medicine, 7, 5, 2020, 55-61.
(2020). 'DNA based CGB methylation in breast cancer a case control study', European Journal of Molecular & Clinical Medicine, 7(5), pp. 55-61.
DNA based CGB methylation in breast cancer a case control study. European Journal of Molecular & Clinical Medicine, 2020; 7(5): 55-61.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 233
  • PDF Download: 309
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus